Ghent University Academic Bibliography

Research Data

MarineNP: A Comprehensive and Locally Deployable Database of Marine Natural Products

Zixia Liu (UGent) , Eveline Diopere (UGent) , Colin Janssen (UGent) and Jana Asselman (UGent)

(2025)

Discovery and characterization of a selective inhibitor of synaptojanin1 5-phosphatase activity

Ella Martin, Danaë Giakoumakis, Jone Paesmans, Nicolò Bisi, Andrzej Drozdzecki (UGent) , Dominique Audenaert (UGent) , Jurgen Haustraete (UGent) , Patrik Verstreken, Christian Galicia, Steven Ballet, et al.

(2025) ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE. 8(9). p.2996-3006

Add to list

Journal Article
A1
open access

Drugging the NLRP3 inflammasome : from signalling mechanisms to therapeutic targets

Lieselotte Vande Walle (UGent) and Mohamed Lamkanfi (UGent)

(2024) NATURE REVIEWS DRUG DISCOVERY. 23(1). p.43-66

Add to list

Journal Article
A1
open access

Proof-of-concept for multiple AON delivery by a single U7snRNA vector to restore splicing defects in ABCA4

Nuria Suárez-Herrera, Iris B. Riswick, Irene Vázquez-Domínguez, Lonneke Duijkers, Dyah W. Karjosukarso, Davide Piccolo, Miriam Bauwens (UGent) , Elfride De Baere (UGent) , Michael E. Cheetham, Alejandro Garanto, et al.

(2024) MOLECULAR THERAPY. 32(3). p.837-851

Add to list

Journal Article
A1
open access

Discovery and development of an advanced lead for the treatment of African trypanosomiasis

Kayhan Ilbeigi, Dorien Mabille, An Matheeussen, Rik Hendrickx, Mathieu Claes, Nick Van Reet, Roel Anthonissen, Fabian Hulpia (UGent) , Cai Lin, Louis Maes, et al.

(2024) ACS INFECTIOUS DISEASES. 11(1). p.131-143

Add to list

Journal Article
A2
open access

Specific autoantibodies and microvascular damage progression assessed by nailfold videocapillaroscopy in systemic sclerosis : are there peculiar associations? An update

Elvis Hysa, Rosanna Campitiello, Silvia Sammorì, Emanuele Gotelli, Andrea Cere, Giampaola Pesce, Carmen Pizzorni, Sabrina Paolino, Alberto Sulli, Vanessa Smith (UGent) , et al.

(2023) ANTIBODIES. 12(1).

Add to list

Journal Article
A1
open access

Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives

Kris Cooreman, Bart De Spiegeleer (UGent) , Christof Van Poucke, David Vanavermaete, Daan Delbare, Evelien Wynendaele (UGent) and Bavo De Witte

(2023) ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY. 102.

Add to list

Journal Article
A1
open access

Structure-function relationship of new peptides activating human Nav1.1

Ludivine Lopez, Stephan De Waard, Hervé Meudal, Cécile Caumes, Kuldip Khakh, Steve Peigneur, Barbara Oliveira-Mendes, Sophia Lin, Jolien De Waele (UGent) , Jérôme Montnach, et al.

(2023) BIOMEDICINE & PHARMACOTHERAPY. 165.

Add to list

Journal Article
A1
open access

Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine

Isabel Leroux-Roels (UGent) , Jacques Bruhwyler, Lilli Stergiou, Mark Sumeray, Jasper Joye, Cathy Maes, Paul-Henri Lambert and Geert Leroux-Roels (UGent)

(2023) VACCINES. 11(2).

Add to list

In vitro and ex vivo models for assessing drug permeation across the cornea

Inès De Hoon, Rabah Boukherroub, Stefaan De Smedt (UGent) , Sabine Szunerits and Félix Sauvage (UGent)

(2023) MOLECULAR PHARMACEUTICS. 20(7). p.3298-3319

Academic Bibliography

MarineNP: A Comprehensive and Locally Deployable Database of Marine Natural Products

Discovery and characterization of a selective inhibitor of synaptojanin1 5-phosphatase activity

Drugging the NLRP3 inflammasome : from signalling mechanisms to therapeutic targets

Proof-of-concept for multiple AON delivery by a single U7snRNA vector to restore splicing defects in ABCA4

Discovery and development of an advanced lead for the treatment of African trypanosomiasis

Specific autoantibodies and microvascular damage progression assessed by nailfold videocapillaroscopy in systemic sclerosis : are there peculiar associations? An update

Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives

Structure-function relationship of new peptides activating human Nav1.1

Double-blind, placebo-controlled, dose-escalating study evaluating the safety and immunogenicity of an epitope-specific chemically defined nanoparticle RSV vaccine

In vitro and ex vivo models for assessing drug permeation across the cornea

Contents

Support

Contact